| Filed On | Filing |
|---|---|
| 11 Sep 2026 |
Form 4: Robertson Stephen P., Chief Legal Officer
Sold 11,939 shares ($190K) |
| 25 Aug 2026 |
Form 4: Robertson Stephen P., Chief Legal Officer
Sold 20,975 shares ($356K) |
| 08 Jun 2026 |
Form 4: Johnson Craig A, Director
Granted 23,931 Director Stock Option (right to buy) |
| 08 Jun 2026 |
Form 4: Goetz Kathleen, Director
Granted 23,931 Director Stock Option (right to buy) |
| 08 Jun 2026 |
Form 4: Nova Tina Susan, Director
Granted 23,931 Director Stock Option (right to buy) |
| 08 Jun 2026 |
Form 4: Bailey Jeffrey Allen, Director
Granted 23,931 Director Stock Option (right to buy) |
| 02 Jun 2026 |
Form 4: Tang Kevin, Director and 1 other
Bought 264,981 shares ($4.06M) · Bought 343,620 shares ($5.25M) · Bought 206,005 shares ($3.15M) · 1 more |
| 20 May 2026 |
Form 4: Robertson Stephen P., Chief Legal Officer
Received 115,541 shares as a grant or award |
| 20 May 2026 |
Form 4: Hearne Michael S, Chief Financial Officer
Received 116,144 shares as a grant or award · Granted 70,230 Employee Stock Option (right to buy) |
| 20 May 2026 |
Form 4: Cole Ryan, Chief Operating Officer
Received 116,144 shares as a grant or award · Granted 70,230 Employee Stock Option (right to buy) |
| 10 Mar 2026 |
Form 4: Keenan Greg, SVP, Chief Medical Officer
Gave up 8,069 shares to cover exercise price or tax ($116K) |
| 03 Mar 2026 |
Form 4: Miller Joseph M, Chief Financial Officer
Received 57,229 shares as a grant or award · Granted 95,700 Employee Stock Option (right to buy) · Gave up 37,511 shares to cover exercise price or tax ($533K) |
| 03 Mar 2026 |
Form 4: Donley Matthew Maxwell, Chief Operating Officer
Received 58,160 shares as a grant or award · Granted 97,256 Employee Stock Option (right to buy) · Gave up 40,761 shares to cover exercise price or tax ($579K) |
| 03 Mar 2026 |
Form 4: Greenleaf Peter, Director
Received 196,403 shares as a grant or award · Granted 328,424 Employee Stock Option (right to buy) · Gave up 100,890 shares to cover exercise price or tax ($1.43M) |
| 03 Mar 2026 |
Form 4: Keenan Greg, SVP, Chief Medical Officer
Received 40,586 shares as a grant or award · Granted 67,870 Employee Stock Option (right to buy) |
| 03 Mar 2026 |
Form 4: Robertson Stephen P., EVP, General Counsel
Received 59,090 shares as a grant or award · Granted 98,813 Employee Stock Option (right to buy) · Gave up 36,525 shares to cover exercise price or tax ($519K) |
| 03 Mar 2026 |
Form 4: Tang Kevin, Director
Bought 516,439 shares ($7.23M) · Bought 199,353 shares ($2.84M) · Bought 184,208 shares ($2.62M) |
| 23 Feb 2026 |
Form 4: Donley Matthew Maxwell, Chief Operating Officer
Gave up 32,901 shares to cover exercise price or tax ($474K) |
| 23 Feb 2026 |
Form 4: Greenleaf Peter, Director
Gave up 100,171 shares to cover exercise price or tax ($1.44M) |
| 23 Feb 2026 |
Form 4: Miller Joseph M, Chief Financial Officer
Gave up 32,424 shares to cover exercise price or tax ($467K) |
Loading...